[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642983":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":41,"centralContacts":48,"locations":53,"responsibleParty":71,"collaborators":11,"id":73,"slug":11,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":11,"eligibilityCriteria":77,"healthyVolunteers":74,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":11,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":11,"overallStatus":90,"whyStopped":11,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Riphah International University","OTHER",[8,14,18,23],{"label":9,"type":10,"description":11,"interventionNames":12},"GRP 1 Tab metformin","ACTIVE_COMPARATOR",null,[13],"Other: GRP 1 Tab metformin",{"label":15,"type":10,"description":11,"interventionNames":16},"GRP 2 Inj insulin",[17],"Other: GRP 2 Inj insulin",{"label":19,"type":20,"description":11,"interventionNames":21},"GRP 3 Tab metformin + HI flora sachet","EXPERIMENTAL",[22],"Other: GRP 3 Tab metformin + HI flora sachet",{"label":24,"type":20,"description":11,"interventionNames":25},"GRP 4 Inj insulin + HI flora",[26],"Other: GRP 4 Inj insulin + HI flora sachet",[28,31,34,37],{"type":6,"name":9,"description":29,"armGroupLabels":30,"otherNames":11},"Tab metformin 500 mg TDS for 12 weeks",[9],{"type":6,"name":15,"description":32,"armGroupLabels":33,"otherNames":11},"Inj insulin s\u002Fc BD for 12 weeks",[15],{"type":6,"name":19,"description":35,"armGroupLabels":36,"otherNames":11},"Tab metformin 500 mg TDS + HI flora sachet OD for 12 weeks",[19],{"type":6,"name":38,"description":39,"armGroupLabels":40,"otherNames":11},"GRP 4 Inj insulin + HI flora sachet","Inj insulin s\u002Fc BD + HI flora sachet OD for 12 weeks",[24],[42,45],{"name":43,"affiliation":5,"role":44},"Jawaria Iftikhar, phd*","PRINCIPAL_INVESTIGATOR",{"name":46,"affiliation":5,"role":47},"Akbar Waheed, PHD","STUDY_DIRECTOR",[49],{"name":43,"role":50,"phone":51,"phoneExt":11,"email":52},"CONTACT","03004219529","jawaria.iftikhar@riphah.edu.pk",[54],{"facility":55,"status":11,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Pakistan Railway Hospital","Rawalpindi","Punjab Province","46000","Pakistan","PK",{"type":62,"coordinates":63},"Point",[64,65],73.0479,33.59733,{"lat":65,"lon":64},[68],{"name":69,"role":50,"phone":70,"phoneExt":11,"email":52},"Jawaria Iftikhar, PHD*","923004219529",{"type":72,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100642983",false,"NCT07645001","Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus","Inclusion Criteria:\n\n* Pregnant women (18-45 years of age).\n* Diagnosed with GDM between 18-26 weeks of gestation.\n* Singleton pregnancy. (Multiple gestations carry inherently higher risks like preterm birth, growth restriction and neonatal morbidity, Inclusion may introduce confounding thus restricting singleton pregnancies ensures population homogeneity).\n\nExclusion Criteria:\n\n* Pre-existing diabetes mellitus.\n* Pregnancy induced hypertension.\n* Chronic gastrointestinal, hepatic, or renal disease.\n* Use of antibiotics or probiotics within the previous 4 weeks.\n* Multiple pregnancy.\n* Pregnancy with known fetal anomalies.","FEMALE","18 Years","45 Years",{"count":82,"type":83},200,"ESTIMATED","INTERVENTIONAL",[86],"NA","1. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on glycemic control and insulin resistance in women with gestational diabetes mellitus (GDM), assessed by FPG, HbA1c, fasting insulin, and HOMA-IR.\n2. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on inflammatory biomarkers in women with GDM.\n3. To determine the effect of multistrain probiotic supplementation alongside standard therapy on maternal and neonatal outcomes, including gestational age at delivery, mode of delivery, birth weight, Apgar score, and NICU admission.",[89],"Gestational Diabetes","NOT_YET_RECRUITING","2026-06-08",{"date":93,"type":94},"2026-06-12","ACTUAL",{"date":96,"type":83},"2026-07",{"date":98,"type":83},"2027-06",{"name":5,"class":6},1]